Trematocidal Synthetic Perioxides
Trematocidal Synthetic Perioxides
批准号:
7648067
负责人:
Jonathan L Vennerstrom
金额:
$15.81万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-15 至 2010-12-30
关键词:
AcidsAcuteAdamantaneAddressAdolescentAdultAffectBile fluidBiological AssayCarboxylic AcidsCellsCharacteristicsChemicalsChronicClonorchis sinensisCountryCyclohexanesDataDiseaseDoseDrug CombinationsDrug KineticsDrug resistanceEnsureEnzymesFasciola hepaticaFascioliasisFeedbackGoalsHepaticHepaticaHumanIn VitroInfectionInhibitory Concentration 50InvestigationLeadLibrariesLiver diseasesMeasuresMetabolicMetabolismModelingMolecular TargetMorbidity - disease rateMuscleMyoblastsOralParasitesPeroxidesPharmaceutical PreparationsPlant RootsPlasmodium falciparumPraziquantelPreventionProdrugsPropertyProtein IsoformsRattusResistance developmentRuralScreening procedureSkeletal MuscleStagingSurfaceTestingToxic effectTreatment EfficacyVaccinesanalogbasecytotoxicitydesigndisorder preventiondrug developmentflexibilityfoodbornefunctional groupin vitro testingin vivoinsightnovelprocess optimizationpublic health relevanceresearch studytriclabendazole
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Food-borne trematodiases affect hundreds of millions of people, particularly the rural poor in the developing world. Since vaccines are currently unavailable, and are unlikely to become available anytime soon for the prevention of food-borne tremotodiases, effective drugs are the only practical means of morbidity control. Importantly, new drugs for these diseases are urgently needed as praziquantel and triclabendazole are the only drugs available and the development of resistance cannot be ignored, particularly in view of the large- scale use of praziquantel in many endemic countries. At the root of this project is our discovery that several synthetic peroxides also possess strong trematocidal activity. We propose to further explore the potential of synthetic peroxides as novel trematocidal drugs. The identification of a new, broad-spectrum, orally-active synthetic peroxide trematocidal drug development candidate will minimize drug-resistance and lead to superior treatment and control options for food-borne trematodiases. Essential characteristics of a new drug development candidate include an economically-feasible and scalable synthesis, excellent oral activity, low potential for toxicity and resistance development, broad spectrum of trematocidal activity, and high efficacy against all parasite stages in the vertebrate host. More specifically, our objective is to identify a drug development candidate with 100% worm burden reductions against juvenile and adult F. hepatica and C. sinensis at doses of < 100 mg/kg and with an excellent ADME profile (predicted ER < 0.30, CYP450 IC50s > 25 5M, oral BA > 30%). To address this overarching objective, we propose the following three specific aims: Specific Aim 1: To synthesize and characterize a focused and structurally diverse library of synthetic peroxides. Specific Aim 2: To assess trematocidal activity and selectivity of target synthetic peroxides against two major human food-borne trematode species, Fasciola hepatica and Clonorchis sinensis. Specific Aim 3: To determine metabolism and pharmacokinetic parameters and initiate mechanism of action studies for selected synthetic peroxides. PUBLIC HEALTH RELEVANCE Food-borne trematodiases, caused by infection with liver flukes, affect hundreds of millions of people, particularly the rural poor in the developing world. Since vaccines are currently unavailable, and are unlikely to become available anytime soon for the prevention of these diseases, new drugs are urgently needed. Praziquantel and triclabendazole are the only drugs now available and the development of resistance cannot be ignored, particularly in view of the large-scale use of praziquantel in many endemic countries. In this proposal, we propose to identify a new broad-spectrum orally-active trematocidal drug development candidate.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.actatropica.2011.02.003
发表时间:
2011-04
期刊:
ACTA TROPICA
影响因子:
2.7
作者:
[Kirchhofer, Carla, Vargas, Mireille, Braissant, Olivier, Dong, Yuxiang, Wang, Xiaofang, Vennerstrom, Jonathan L., Keiser, Jennifer]
通讯作者:
Keiser, Jennifer
DOI:
10.1021/jm100226t
发表时间:
2010-05-27
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Zhao Q, Vargas M, Dong Y, Zhou L, Wang X, Sriraghavan K, Keiser J, Vennerstrom JL]
通讯作者:
Vennerstrom JL
Tetrasubstituted pyrazinones derived from the reaction of praziquantel with N-bromosuccinimide.
由吡喹酮与N-溴代琥珀酰亚胺反应衍生的四取代吡嗪酮。
DOI:
10.1016/j.tetlet.2014.06.083
发表时间:
2014
期刊:
Tetrahedron letters
影响因子:
1.8
作者:
[Zhao,Qingjie, Wang,Chunkai, Ezell,EdwardL, Dong,Yuxiang, Vennerstrom,JonathanL]
通讯作者:
Vennerstrom,JonathanL
The activity of dispiro peroxides against Fasciola hepatica.
二螺过氧化物对肝片形吸虫的活性。
DOI:
10.1016/j.bmcl.2011.07.024
发表时间:
2011
期刊:
Bioorganic & medicinal chemistry letters
影响因子:
2.7
作者:
[Wang,Xiaofang, Zhao,Qingjie, Vargas,Mireille, Dong,Yuxiang, Sriraghavan,Kamaraj, Keiser,Jennifer, Vennerstrom,JonathanL]
通讯作者:
Vennerstrom,JonathanL
Optimization of Antischistosomal Chemotypes
-
批准号:8998926
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2015
-
负责人:Jonathan L Vennerstrom
-
依托单位:
Optimization of Antischistosomal Chemotypes
-
批准号:10598486
-
项目类别:
-
资助金额:$61.96万
-
财政年份:2015
-
负责人:Jonathan L Vennerstrom
-
依托单位:
Optimization of Antischistosomal Chemotypes
-
批准号:8861056
-
项目类别:
-
资助金额:$62.39万
-
财政年份:2015
-
负责人:Jonathan L Vennerstrom
-
依托单位:
Optimization of Antischistosomal Chemotypes
-
批准号:10374891
-
项目类别:
-
资助金额:$62.56万
-
财政年份:2015
-
负责人:Jonathan L Vennerstrom
-
依托单位:
Leveraging RC-12 for Radical Cure of Plasmodium Vivax
-
批准号:8430756
-
项目类别:
-
资助金额:$21.29万
-
财政年份:2013
-
负责人:Jonathan L Vennerstrom
-
依托单位:
Increasing the Antischistosomal Selectivity of Aryl Hydantoins
-
批准号:8374010
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2012
-
负责人:Jonathan L Vennerstrom
-
依托单位:
Increasing the Antischistosomal Selectivity of Aryl Hydantoins
-
批准号:8523778
-
项目类别:
-
资助金额:$14.94万
-
财政年份:2012
-
负责人:Jonathan L Vennerstrom
-
依托单位:
Trematocidal Synthetic Perioxides
-
批准号:7530331
-
项目类别:
-
资助金额:$20.38万
-
财政年份:2008
-
负责人:Jonathan L Vennerstrom
-
依托单位:
METABOLIC STABILITY IN ANTIMALARIAL TETRAOXANES
-
批准号:2076710
-
项目类别:
-
资助金额:$10.67万
-
财政年份:1996
-
负责人:Jonathan L Vennerstrom
-
依托单位:
OXIDANTS AS SITE-SPECIFIC ANTIMALARIALS
-
批准号:3436754
-
项目类别:
-
资助金额:$10.08万
-
财政年份:1989
-
负责人:Jonathan L Vennerstrom
-
依托单位:
海外基金